Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
18/06 | INNOVIVA, INC. : Opinion positive de Cantor Fitzgerald | ZM |
10/06 | Transcript : Innoviva, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 01:20 PM |
CA 2024 * | 303 M 272 M | CA 2025 * | 319 M 287 M | Capitalisation | 1,02 Md 920 M |
---|---|---|---|---|---|
Résultat net 2024 * | - | Résultat net 2025 * | - | VE / CA 2024 * | 4,12 x |
Dette nette 2024 * | 224 M 201 M | Dette nette 2025 * | 145 M 130 M | VE / CA 2025 * | 3,66 x |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 65,49% |
Dernier transcript sur Theravance Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20/05/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 21/08/23 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 01/10/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 64 | 12/02/18 | |
Director/Board Member | 53 | 01/01/23 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 12/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32% | 815 Md | |
+44,05% | 641 Md | |
-6,75% | 352 Md | |
+13,56% | 314 Md | |
+10,68% | 303 Md | |
+16,57% | 242 Md | |
+13,31% | 218 Md | |
+8,48% | 168 Md | |
-2,81% | 159 Md |
- Bourse
- Actions
- Action INVA
- Action